Both neurocognitive deficits and schizophrenia are highly heritable. Genetic overlap between neurocognitive deficits and schizophrenia has been observed in both the general population and in the clinical samples. This study aimed to examine if the polygenic architecture of susceptibility to schizophrenia modified neurocognitive performance in schizophrenia patients. Schizophrenia polygenic risk scores (PRSs) were first derived from the Psychiatric Genomics Consortium (PGC) on schizophrenia, and then the scores were calculated in our independent sample of 1130 schizophrenia trios, who had PsychChip data and were part of the Schizophrenia Families from Taiwan project. Pseudocontrols generated from the nontransmitted parental alleles of the parents in these trios were compared with alleles in schizophrenia patients in assessing the replicability of PGC-derived susceptibility variants. Schizophrenia PRS at the P-value threshold (PT) of 0.1 explained 0.2% in the variance of disease status in this Han-Taiwanese samples, and the score itself had a P-value 0.05 for the association test with the disorder. Each patient underwent neurocognitive evaluation on sustained attention using the continuous performance test and executive function using the Wisconsin Card Sorting Test. We applied a structural equation model to construct the neurocognitive latent variable estimated from multiple measured indices in these 2 tests, and then tested the association between the PRS and the neurocognitive latent variable. Higher schizophrenia PRS generated at the PT of 0.1 was significantly associated with poorer neurocognitive performance with explained variance 0.5%. Our findings indicated that schizophrenia susceptibility variants modify the neurocognitive performance in schizophrenia patients.
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Schizophrenia is a severe mental disorder characterized by impairments in cognitive function (Kahn & Keefe 2013) . Compared with the general population, youths with psychotic symptoms have delayed neurocognitive age relative to chronological age, and more significant psychotic symptoms are associated with a greater developmental lag (Gur et al. 2014) . A longitudinal study found that cognitive deficits are already apparent prior to psychosis onset (Reichenberg et al. 2009 ). The spectrum of neurocognitive deficit, a patient-specific factor, could serve as an endophenotype of schizophrenia (Chen 2013) , and it is strongly determined by genetic factors. A meta-analysis suggested that there is no evidence of cognitive decline after onset among patients with psychosis (Bora & Murray 2013) , although another meta-analysis found that there is IQ decline during the course of schizophrenia (Hedman et al. 2013) .
Both general cognition (Davies et al. 2011 ) and schizophrenia (Polderman et al. 2015) are highly heritable. Family studies and twin studies indicated that the correlation between the two phenotypes is substantial, and the covariance between the two is mostly explained by common genetic variants (Toulopoulou et al. 2007; Aukes et al. 2009) . Recently a twin study showed that genetic susceptibility to schizophrenia was shared with that of intelligence and brain structure (Bohlken et al. 2016) , and another large genome-wide association study (GWAS) reported polygenic overlap between schizophrenia and educational attainment (Le Hellard et al. 2016) . It is likely that sets of specific variants associated with susceptibility to schizophrenia could explain some variation of neurocognitive performance. One established approach to explore genetic overlap between phenotypes is to apply polygenic architecture profiling. By retrieving the summary data from a GWAS of a discovery sample, the selection of associated variants and its corresponding weight was preserved. Then in another independent sample, the cumulative additive effect of thousands of disease-associated single nucleotide polymorphisms (SNPs) were combined into a single polygenic risk score (PRS), and the association between the PRS and the outcome of interest was tested further (Purcell et al. 2009) .
Recently, it has been shown that polygenic profiling of schizophrenia risk genetic variants predict alteration in total brain and white matter volume (Van Scheltinga et al. 2013b) , and a variety of cognitive domains (Mcintosh et al. 2013; Kauppi et al. 2014; Lencz et al. 2014; Hatzimanolis et al. 2015; Hubbard et al. 2016) . In addition, sets of genes associated with cognitive functions in general population were shown to be associated with schizophrenia (Fernandes et al. 2013) . However, some studies reported a lack of association with white matter volume in healthy subjects (Papiol et al. 2014) , cognitive performance in the general population and intelligence in patients with schizophrenia as well as healthy controls (Van Scheltinga et al. 2013a) .
It is important to explore which degree alterations on neurocognitive deficient observed in schizophrenia are modulated by genetics which may involve in disease etiology. For patients with schizophrenia and their nonpsychotic first-degree relatives, those from multiplex families showed more neurocognitive deficits than those from simplex families (Lin et al. 2013) . This indicated that genetic risk of schizophrenia was associated with neurocognitive performance. Several studies have shown that polygenic score of schizophrenia was associated with schizophrenia-associated traits, however, some studies did not replicate the findings. Also, the genetic overlap between neurocognitive deficient and schizophrenia has been observed in general population (Lencz et al. 2014; Hatzimanolis et al. 2015) , but this need to be further explored in clinical population, which further indicates whether the common variants associated with schizophrenia modify the neurocognitive performance in schizophrenia patients.
This study aimed to examine if neurocognitive performance can be attributed to polygenic architecture of schizophrenia in clinical populations. Schizophrenia PRSs were calculated using information from the Psychiatric GWAS Consortium (PGC), in which the majority of PGC samples are Caucasian, on schizophrenia. The PGC data was used as a discovery sample to identify the schizophrenia risk variants with P-values below different cut-offs. Summary results from PGC data were used to calculate individual PRS in our independent Han-Taiwanese samples. The specific aim of this study was to examine if the schizophrenia PRS is associated with neurocognitive deficit among patients with schizophrenia.
Materials and methods

Participants
Schizophrenia probands and their first-degree relatives were recruited from Schizophrenia Trio Genomic Research in Taiwan (S-TOGET) funded by National Institute of Mental Health. A total of 3093 schizophrenia patients from 3008 families were interviewed with the Diagnostic Interview for Genetic Studies (DIGS), which was designed specifically for family-genetic studies of schizophrenia and bipolar disorder with good interrater reliability. Among them, 2923 schizophrenia probands were from simplex family. The Chinese version of the DIGS and its reliability have been described previously. Interviews using the Chinese version of the DIGS were conducted by research assistants who had received standardized psychiatric interview training. Research diagnostic assessment was made independently by two board-certified psychiatrists based on integrated clinical information of DIGS interview data and summary note of clinical course, symptom manifestations and social functioning derived from the records of the medical charts according to Diagnostic and Statistical Manual of Mental Disorders, Fourth edition, for schizophrenia. If both psychiatrists disagreed about a diagnosis, a third psychiatrist was sought, and a consensus diagnosis was reached after discussion.
The DIGS includes a psychosis section that inquires about age at onset of the first psychotic episode that could not be attributed to medical illness, medications or substance abuse. When information about onset of the first psychotic episode in the interview was unclear, research psychiatrists reviewed the medical history and determined the onset age.
This study was approved by the institutional review boards of the participating hospitals. Written informed consent was obtained from all subjects after complete description.
Genetic analysis
A total of 1130 trios, including 1130 schizophrenia patients and 2260 healthy parents, of simplex families were genotyped using the PsychChip array funded by PGC, the Stanley Center for Psychiatric Research, the Friedman Brain Institute, and the Icahn Institute for Genomics and Multiscale Biology at Mount Sinai. Initial quality control was performed by the PGC, removing individuals with more than 2% missing variants. The variants were filtered based on call rate <2%, deviation from Hardy-Weinberg equilibrium with P < 1 × 10 −6 in controls and P < 1 × 10 −10 in cases. These variants were used to calculate multidimensional scaling components in order to account for ancestry. After quality control, 1120 probands remained.
Data from the PGC meta-analysis, including pgc and pgc2, were used as a discovery sample to identify the schizophrenia risk variants. Set of variants with P-value below certain cut-offs for association test with schizophrenia were chosen for the following thresholds: 0.5, 0.1 and 0.05, which are the thresholds that maximally captures the heritability of schizophrenia (Consortium 2011; Ripke et al. 2014) . Variants genotyped in the S-TOGET sample were used for the generation of PRS. To remove variants in linkage disequilibrium (LD), variants were pruned with a pairwise R 2 threshold of 0.25 and a sliding window size of 50 SNPs. For each subject in our independent sample, the schizophrenia PRS was calculated using PLINK "score" procedure (Purcell et al. 2007) . The range of quantitative PRS is small (Table S1 , Supporting Information), and this could result in immoderate values for estimated coefficients in regression analyses. For easy interpretation, the PRS were categorized into tertiles (Sokolowski et al. 2015) . For sensitivity analyses, the PRS were also categorized into different categorical quantiles, including quartiles and deciles.
To assess the replicability of PGC-derived susceptibility variants in this Han-Taiwanese data, pseudocontrols were generated from the nontransmitted parental alleles of the parents by the PLINK "tucc" procedure. The association between the PRS and the disease status and the proportion of variation explained was evaluated by conditional logistic regression and the Nagelkerke's pseudo-R 2 .
Neurocognitive measurements
The dimensions of neurocognitive performance in this study included sustained attention deficit as measured on continuous performance test (CPT) and executive function as measured on Wisconsin Card Sorting Test (WCST) (Chen 2013) . Of the probands with PsychChip data, 995 had information on undegraded CPT, 967 on degraded CPT, and 964 on WCST (128 cards). The degraded and undegraded version of CPT, which was used to assess substained attention, has been described in detail elsewhere (Chen et al. 1998) . The signal-detection indices, sensitivity (d ′ ) and response criterion (ln ), were derived from the hit rate (probability of response to target trials) and false-alarm rate (probability of response to nontarget trials). The sensitivity reflects an individual's ability to discriminate target stimuli from nontarget stimuli and the response criterion measures the amount of perceptual evidence an individual requires prior to making a decision to respond to a stimulus as a signal. The adjusted Z scores of the CPT indices were derived with adjustments for sex, age and education against a community sample of 345 individuals (Chen et al. 1998) .
The computerized version of WCST was used to assess executive functioning (Lin et al. 2013) . Nine performance indices were derived: total errors (TE), perseverative errors (PE), nonperseverative errors (NE), perseverative responses (PR), categories achieved (CA), conceptual level response (CL), trials to complete first category (TC), failure to maintain set (FM) and learning to learn (LL). Total error is a linear combination of PE and NE and thus redundant; LL was not included because many subjects did not achieve the required degree of success. The adjusted Z scores of the CPT indices were derived with adjustments for sex, age and education against the group of 440 normal controls (Lin et al. 2013 ).
Statistical analysis
We first conducted exploratory factor analyses with VARIMAX rotation of the 7 indices of WCST, and retained factors that have eigenvalues greater than 1. The containing items for each factor were selected with factor loadings larger than 0.5. Then, we conducted confirmatory factor analyses to estimate the latent score of neurocognitive performance from CPT and WCST indices. We fixed the variance of latent variables to 1 to obtain standardized factor loadings, which indicated the correlation between latent variables and manifest variables. Model fit was assessed by comparative fit index (CFI) and standardized root mean square residual (SRMR) (Wang & Wang 2012) . The value of the CFI greater than 0.9 and the value of SRMR smaller than 0.08 indicated a good fit. Factor analyses were conducted using Mplus.
After applying structural equation modeling to construct latent variables from multiple-measured indices in CPT and WCST, we then tested the association between the PRS and the neurocognitive latent variable. For the purpose of interpretation, we categorized the latent score of neurocognitive performance, a continuous variable, into deciles. Then, we conducted ordinal logistic regression to explore the association between neurocognitive performance and schizophrenia PRS. In addition, we explored the association between the PRS and the individual CPT/WCST indices.
Results
Demographic features
Distribution of sociodemographic characteristics among 1120 probands with PsychChip data was shown in Table 1 . The distribution of raw score and adjusted Z score of CPT and WCST indices were shown in Table S2 .
PRS for schizophrenia: association with schizophrenia in S-TOGET
Variances explained and P-values of the association between the PRS derived from pgc and pgc2, respectively, and schizophrenia in S-TOGET are summarized in Fig. 1 and Table  S3 . The PRS derived from pgc at the P-value threshold of 0.1 explained the most variance of the schizophrenia in Figure 1: Variance explained of the association between schizophrenia polygenic score, generated from pgc (a) and pgc2 (b), respectively, and schizophrenia in S-TOGET trios data. The P-values shown are those for the quantitative or categorical risk scores with the lowest value for association test in S-TOGET for different P-value thresholds of retaining SNPs in pgc or pgc2 dataset.
S-TOGET trio data [OR (odds ratio) per tertile increase in PRS = 1.11, R 2 = 0.2%, P-value = 0.05]. The pattern of the association remained similar across different P-value thresholds from 0.5 to 0.05 as well as for different categorical quantiles of the PRS or the quantitative PRS derived from pgc, although some failed to reach statistical significance. No evidence of association was shown when using pgc2 as a discovery sample (P-value ranging from 0.17 to 0.96). Hence, we used pgc as the discovery sample in subsequent analyses.
Factor analyses of neurocognitive performance
The exploratory factor analysis suggested a two factor model for WCST. The four-latent factor (two for WCST, one for CPT and one for neurocognitive performance) model was subsequently tested with confirmatory factor analysis. The CFI and SRMR were 0.897 and 0.055, respectively, indicating a good fit. The structure of the model was shown in Fig.  S1 . The higher score of neurocognitive performance indicated the better performance.
PRS for schizophrenia: association with neurocognitive performance in S-TOGET
The results of association between schizophrenia PRS derived from pgc and neurocognitive performance were shown in Fig. 2 and Table 2 . Schizophrenia PRS at threshold 0.1 was associated with poorer neurocognitive performance (OR per tertile increase in PRS = 0.86, R 2 = 0.5%, P-value = 0.03). The pattern of association remained across different thresholds from 0.5 to 0.05 and different categorical quantiles of PRS as well as quantitative PRS.
The results of association between PRS and adjusted Z scores of individual CPT and WCST indices were presented in Table 3 . Schizophrenia PRS at threshold 0.1 was associated with PR, PE, CL and FM, and the direction of estimated coefficient was consistent under different threshold from 0.05 to 0.5.
Discussion
We provided evidence for polygenic overlap between schizophrenia and neurocognitive performance in clinical population, and the results extended the previous findings that observed this association in general population (Lencz et al. 2014; Hatzimanolis et al. 2015) . The derived PRS is a mix of true-associated and null common variants of a trait, and the power maximizes at P-value threshold when the PRS is most enriched with true signals. The composition of a PRS seemed to reach a better balance between true and null effect under non-conservative P-value threshold (Consortium 2011; Ripke et al. 2014; Jones et al. 2016) . Our results shown that schizophrenia PRS explained about 0.5% of variability for neurocognitive performance in schizophrenia patients, and the estimated R 2 is similar to that reported in general population, about 0.3% for sustained attention and working memory (Hatzimanolis et al. 2015) . The latent structure of WCST has been explored by principal component analysis, exploratory factor analysis, and confirmatory factor analysis (Polgár et al. 2010) . Different studies used different subject groups and various WCST measures, and many suggested a three-factor solution, including general executive functioning, problem solving and response maintenance. The indices loaded on general executive functioning including PE, PR, CL, CA and this factor is corresponding to WCST2 in this study. Indices respect to NE and FM loaded most frequently on problem solving and response maintenance, respectively, and these two indices loaded on WCST1 and WCST2, respectively, in this study. The dimension on response maintenance was combined with general executive functioning in our results from confirmatory factor analysis. This study used large samples as well as homogeneous subject group, only schizophrenia patients, and thus derived the reliable solutions, which partly replicated the general factor structure of the WCST that has been studied previously (Greve et al. 2005) .
This study used a large schizophrenia GWAS as a training dataset, and the susceptibility variants for schizophrenia reported in pgc predicted schizophrenia in Taiwanese trios data, although the PRS used in this study explained only 0.2% of disease status, whereas the large scale study reported an explained variance of 3-18% (Purcell et al. 2009; Ripke et al. 2014) . Furthermore, we have a large collection of clinical samples with a range of neurocognitive domains including executive function and attention.
A potential limitation of this study is the inconsistent results in replicating the pgc and replicating the pgc2 polygenic findings in our Taiwanese trios data as well as the less overlapping between schizophrenia PRS and schizophrenia than that observed with neurocognitive performance. Hence, our positive results for replicating the pgc polygenic findings in this data might be accounted for by multiple testing as the P values observed with the pgc are modest. However, with the prior positive findings (Consortium 2011; Ripke et al. 2014) , the positive result for pgc would reflect an underlying true signal, and the inconsistent results could be caused by ancestral heterogeneity. The sample size of pgc2 increased substantially, meanwhile its heterogeneity of ancestry (49 of European and 3 of east Asian ancestry vs. 17 of European ancestry in pgc) also became higher than that of pgc (Consortium 2011; Ripke et al. 2014) . Furthermore, there is a difference in sex distribution between PGC (overall >50% being male) and this Taiwanese patient sample (40% being male). In this study, the sex-, age-and education-adjusted Z scores of the neurocognitive indices were derived to diminish the potential impact of sex difference on neurocognitive performance. There is another difference in the study design between PGC, case-control association analyses, and this study, case-parents trio association analyses. The case-control association analyses could be biased due to population stratification, whereas trios data are free of such bias. In general, comparing differently designed data sets to each other tends to result in some loss of power. This might explain in part why our data replicate only the pgc of less ancestral heterogeneity. Another limitation is that rare genetic variants and many common genetic variants are not genotyped by the PsychChip array, hence we captured less genetic overlap between neurocognitive performance and schizophrenia. In addition, the tests were conducted at multiple P-value thresholds, hence multiple testing problems occurred. But the direction of association across different threshold as well as different categorical quantiles of score is consistent in this study, the association reported is less likely to have arisen due to type I error. Finally, the neurocognitive battery used in this study was limited. A larger battery will provide more information for more discrete domains of neurocognitive function.
The applicability and limitations of the PRS approach has been summarized by a review (Maher 2015) , and the power and predictive accuracy of PRS has also been well studied (Dudbridge 2013) . The polygenic scoring approach did not account for the effects of LD. The SNPs in regions of higher LD may capture more variance associated with a causal variant, and hence result to a higher test statistics in association analysis . Bulik-Sullivan proposed LD score regression to distinguish between confounding bias and polygenicity (Bulik-Sullivan et al. 2015a; Bulik-Sullivan et al. 2015b ). The LD regression, which derives genetic correlations across traits based on summary data from GWAS, was suitable to studies without individual genotype data, and the approach has been used to examine the link between general cognitive function and several major psychiatric disorders (Hill et al. 2015) . But, compared with methods using individual genotypes, the LD regression requires larger sample sizes to achieve equivalent efficacy. Also, the LD regression is not suitable to samples with admixed populations.
Pruning for LD in polygenic scoring approach may result in loss of power as informative markers may be lost. LDpred, a recently proposed method accounting for the effects of linked markers, increases the heritability estimates (Vilhjálmsson et al. 2015) . However, the LDpred requires LD information form an external reference panel in addition to training samples and target samples. Otherwise, the prediction accuracy might be compromised when prediction in diverse population.
Conclusions
This study examined if polygenic profiling of common schizophrenia risk genetic variants is associated with neurocognitive performance in clinical samples. We have shown the replicability of PGC-derived susceptibility variants in Taiwanese samples. Our results indicated that the polygenic architecture of susceptibility to schizophrenia modified the neurocognitive performance in schizophrenia patients. Increasing genetic risk of schizophrenia was associated with poor neurocognitive performance. CMU105-N-15 from China Medical University in Taiwan, the Gerber Foundation, the Sidney R. Baer, Jr. Foundation, NARSAD: The Brain and Behavior Research Foundation, and the Stanley Center for Psychiatric Research. The authors declared no conflict of interest.
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